Clinical Trials on Salivary Gland Neoplasm in Belgium

Total 4145 results

European Organisation for Research and Treatment...

Active, not recruiting

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Salivary Gland Cancer

Belgium, France, Netherlands, Italy, Hungary, Germany, Austria, Greece
Universitair Ziekenhuis Brussel
Kom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie...

Recruiting

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients (VUBAR)

Gastric Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract Cancer | Locally Advanced Breast Cancer | Cancer of Pancreas | Uterine Cancer | Salivary Gland Cancer | Metastatic Breast Carcinoma | Solid Tumor With Intermediate...

Belgium
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer

Head and Neck Neoplasms | Deglutition Disorders | Xerostomia

Belgium
Erasme University Hospital

Recruiting

Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses

Pulmonary Nodule, Solitary

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.

Nodule Solitary Thyroid | Toxic Multinodular Goiter | Radioactive Iodine-Induced Hypothyroidism

Belgium
University Hospital, Ghent
XEOS Medical

Completed

Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT

Head and Neck Neoplasms | Thyroid Neoplasm | Skin Neoplasm

Belgium
AstraZeneca
Daiichi Sankyo Co., Ltd.

Active, not recruiting

A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (DPT01)

Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast

Italy, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
Universitair Ziekenhuis Brussel

Recruiting

Sub-type Specific Genomic Mutations in sBOTs

Ovarian Neoplasm Epithelial

Belgium
University Hospital, Gasthuisberg

Completed

Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)

Neoplasm | Pancreas

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Distress, Anxiety and Psychosexual Health in BOT

Ovarian Neoplasm Epithelial Borderline

Belgium
University Hospital, Antwerp

Recruiting

Integrated Genetic and Functional Analysis of the Female Microbiome in a Flemish Cohort (Isala)

Skin Microbiome | Vaginal Microbiome | Saliva Microbiome

Belgium
KU Leuven
Agentschap voor Innovatie door Wetenschap en Technologie; Research Foundation...

Completed

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

Adenocarcinoma | Pancreatic Neoplasms | Monitoring, Immunologic | Neoplasm Circulating Cells | Tumor Markers, Biological

Belgium
General Hospital Groeninge

Completed

Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy (PSMLOPD)

Pancreatic Neoplasms

Belgium
University Hospital, Ghent

Completed

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

Thyroid Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

Ovarian Cancer | Peritoneal Metastasis

Belgium
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
University Hospital, Gasthuisberg

Completed

Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy (ERAMIP)

Pancreatic Neoplasms; Periampullary Neoplasms

Belgium
University Hospital, Ghent

Recruiting

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) (PeRFormanCe)

Pancreatic Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
AstraZeneca

Active, not recruiting

Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer (CLIO)

Ovarian Epithelial Cancer

Belgium
Erasme University Hospital
Jules Bordet Institute; University Hospital St Luc, Brussels; Belgian Group of...

Recruiting

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma (STEREOPAC)

Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | Pancreatic Neoplasm

Belgium
KU Leuven
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma (ECLNI DPAC)

Pancreatic Neoplasms | Pancreatic Adenocarcinoma

Belgium
KU Leuven

Unknown

Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery (IOTA7)

Patients With Adnexal Mass Prior to Surgery

Belgium
Baki Topal
AstraZeneca

Active, not recruiting

Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer (MIMIPAC)

Pancreatic Cancer Non-resectable

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer (S53580)

Ovarian Carcinoma

Belgium
KU Leuven

Unknown

Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules (IOTA-MRI)

Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules

Belgium
Jules Bordet Institute

Completed

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Ovarian Carcinoma | Relapse

Belgium
University Hospital, Ghent

Recruiting

Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology (DCE-MRI)

Ovarian Cancer | Colon Cancer | Pancreas Cancer | Carcinomatosis, Peritoneal

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Radiofrequency Ablation for Biliopancreatic Malignancy (IGNITE-1)

Cholangiocarcinoma | Pancreas Cancer | Obstructive Jaundice

Belgium
Jules Bordet Institute

Completed

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients (OV-AP-ICG-IV)

Ovarian Cancer | Peritoneal Carcinomatosis

Belgium
University Hospital, Ghent

Completed

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer (OvIP1)

Ovarian Cancer | Primary Peritoneal Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer (VIPIDO)

Ovarian Cancer

Belgium
Baki Topal

Withdrawn

Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery

Surgery | Pancreatic Tumour | Peri-ampullary Tumour | Blood Loss

Belgium
University Hospital, Ghent
University Ghent; Kom Op Tegen Kanker

Recruiting

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer (PIPAC-NAL-IRI)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Small Bowel Cancer | Bile Duct Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Appendix Cancer

Belgium
Jules Bordet Institute

Completed

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma

Belgium
Hoffmann-La Roche

Active, not recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

Melanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditions

United States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
Genzyme, a Sanofi Company

Completed

CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice (CaprelsaReg)

Metastatic Medullary Thyroid Cancer

Belgium
PharmaMar

Completed

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

Metastatic Colorectal Cancer | Pancreatic Cancer | Metastatic Breast Cancer

Spain, Belgium
University of Zurich

Terminated

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

Pancreatic Cancer

France, Switzerland, Belgium, Germany
University Hospital, Antwerp
Kom Op Tegen Kanker; Stichting tegen Kanker

Recruiting

First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients (IL15-TransDC)

Esophageal Cancer | Ovarian Cancer | Pancreas Cancer | Liver Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Gasthuis Zusters Antwerpen

Recruiting

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors (NARCiS)

Glioma | Pituitary Adenoma | Brain Tumor | Magnetic Resonance Imaging | Meningioma | Cognition

Belgium
Jules Bordet Institute

Recruiting

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis (FAPeCa)

Cancer | Peritoneal Carcinomatosis

Belgium
Azienda Ospedaliera Universitaria Integrata Verona

Completed

EUS-FNB With ROSE Vs. EUS-FNB Without ROSE (FROSENOR)

Pancreatic Neoplasm | Biopsy, Fine-needle

Netherlands, Sweden, Australia, Japan, Italy, Belgium, United States, Spain
University Hospital, Ghent

Recruiting

A Performance Study of (Opportunistic) Salpingectomy (QOS)

Ovarian Cancer | Adnexal Lesion

Belgium
Jules Bordet Institute
University Hospital, Ghent

Completed

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Colorectal Neoplasm | Secondary Malignant Neoplasm of Liver

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Endobronchial Valves in Persistent Air Leak

Malignant Neoplasm of Lung

Belgium
Jean-Luc Van Laethem
Roche Pharma AG

Unknown

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer (NEOPACHI-001)

Pancreatic Adenocarcinoma Resectable

Belgium
Jules Bordet Institute

Completed

Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases (OvEpiLyPath)

Carcinomatosis, Peritoneal

Belgium
Cancer Research Antwerp

Recruiting

Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC) (MASSC)

Head and Neck Neoplasm

Belgium
Clavis Pharma

Completed

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Ovarian Cancer

Belgium, Italy
Merck KGaA, Darmstadt, Germany

Completed

AS703569 and Gemcitabine Combination in Advanced Malignancies

Pancreatic Cancer

Belgium, France

Clinical Trials on Salivary Gland Neoplasm in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations